Biotech Values

[DewDiligence]

PlantForm, PharmaPraxis ink FoB collaboration for Brazilian market:

http://t.co/RyO9nD8pZG

PlantForm Corporation of Canada and PharmaPraxis of Brazil are pleased to announce the establishment of a joint venture to develop, manufacture and commercialize biosimilar and/or biobetter versions of six key biopharmaceuticals for the Brazilian market, using PlantForm’s low-cost manufacturing system.

The joint venture will first develop a biosimilar/biobetter version of the oncology drug Avastin (bevacizumab), in collaboration with the Fraunhofer Center for Molecular Biology in Newark, Delaware, USA, which will produce the active pharmaceutical ingredient for clinical trials.

Brazilian government corporation Bio-Manguinhos will also participate in the project. Bio- Manguinhos is responsible for technology development and production of vaccines, reagents and biopharmaceuticals to meet public health demands.

These companies are not exactly household names, but there is money to be made by somebody selling FoBs in Brazil.